Study compares first-year costs of HD and PD8/13/2009 10:53:47 AM
Commercially-insured peritoneal dialysis patients will cost the payer less in the first year than patients who start on in-center hemodialysis, according to a new study.
The paper, "Peritoneal dialysis versus hemodialysis in patients with end‐stage renal disease: A comparison of health care utilization and cost," was published this week in the American Journal of Managed Care.
Using the PharMetrics Patient‐Centric Database, a 14 million member claims database from over 85 U.S. health plans, the authors identified PD and in-center HD patients who began dialysis between January 1, 2004 and December 31, 2006. A total of 463 patients met all study criteria; 56 (12%) began treatment with PD and 407 (88%) with in-center HD. Fifty PD patients could be propensity‐matched to an equal number of HD patients.
The results showed that HD patients were more than twice as likely as matched PD patients to be hospitalized during follow‐up. Their median health care costs over the 12‐month follow‐up period were $43,510 higher ($173,507 vs $129,997 for PD).
The authors acknowledged that on average, PD patients in the study were younger than the HD group. Fewer of the PD patients had a history of congestive heart failure; more had renal osteodystrophy. Health care costs during pre-ESRD treatment were slightly higher among PD patients.
In the absence of head‐to‐head clinical trials, which may never be conducted, observational studies such as ours may be the only means of comparing health care utilization and costs in patients beginning dialysis with HD versus PD, the authors wrote.
The study was funded by Baxter Healthcare Corporation.
http://www.nephronline.com/features.asp?F_ID=459